EXPLAIN

  • Research type

    Research Study

  • Full title

    Hyperpolarised Xenon Magnetic Resonance PuLmonary Imaging in PAtieNts with Long-COVID (EXPLAIN)

  • IRAS ID

    305846

  • Contact name

    Fergus V Gleeson

  • Contact email

    fgleeson@oncology.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    We wish to understand why some individuals with long-COVID struggle with breathlessness on exertion (when active) and have a reduced ability to exercise. To do this, we will use MRI scanning and a special gas (hyperpolarised xenon) which is breathed in during the scan. The xenon gas is harmless in the quantity we use. This technique shows the movement of xenon within the lungs and moving out of the lungs into the bloodstream, similar to how oxygen is absorbed. In patients hospitalised with COVID-19, we found that the xenon MRI scans several months after discharge showed lung damage, even when other tests were normal. Importantly, on follow-up imaging, some have remained abnormal.
    Our aim is to further our understanding of some of the factors that cause symptoms in Long-COVID, and provide a much needed explanation to individuals struggling with breathlessness. Learning more about the nature of damage within the lungs through xenon MRI may help with the future development of treatments, and provide a reliable way of measuring the treatment response over time.

  • REC name

    South Central - Oxford C Research Ethics Committee

  • REC reference

    21/SC/0398

  • Date of REC Opinion

    15 Dec 2021

  • REC opinion

    Further Information Favourable Opinion